Page 302 - Tata_Chemicals_yearly-reports-2021-22
P. 302

Integrated Annual Report 2021-22




           Summarised financial information of Non-controlling interests
           Note - i
           Rallis India Limited (“Rallis”)
                                                                                                      ₹ in crore
                                                                                     Year ended    Year ended
           Movement of Non-controlling interest
                                                                                 March 31, 2022  March 31, 2021
           Opening carrying value as at April 1                                         851.91         763.08
           NCI’s share of profit for the year                                            81.77         112.41
           NCI’s share of other comprehensive income for the year                        (0.32)          0.70
           Dividends received for the year                                              (29.14)        (24.28)
           Change due to dissolution of subsidiary                                        0.28             -
           Closing carrying value as at March 31                                        904.50        851.91

                                                                                                      ₹ in crore
                                                                                         As at          As at
           Summarised Statement of Assets and Liabilities
                                                                                 March 31, 2022  March 31, 2021
           Current assets                                                              1,793.96       1,655.41
           Non-current assets                                                          1,064.08        933.21
           Current liabilities                                                        (1,076.67)      (914.47)
           Non-current liabilities                                                      (84.71)        (82.66)
           NCI                                                                               -          (0.69)
           Net assets                                                                  1,696.66      1,590.80
           Proportion of the NCI                                                        49.94%         49.94%
           NCI share in carrying amount                                                 847.31         794.45
           Add: Fair value adjustments for NCI (Ind-AS 103)                              57.19          57.46
           Carrying amount of the NCI                                                   904.50        851.91

                                                                                                      ₹ in crore
                                                                                     Year ended    Year ended
           Summarised Statement of Profit and Loss
                                                                                 March 31, 2022  March 31, 2021
           Revenue and other income                                                    2,631.39       2,469.89
           Cost of raw material consumed                                              (1,561.57)     (1,407.55)
           Purchase of stock-in-trade                                                  (119.90)       (136.59)
           Changes in inventories of finished goods, work-in-progress and stock-in-trade  57.90         68.93
           Employee benefits expense                                                   (239.14)       (216.00)
           Finance cost                                                                  (4.79)         (5.21)
           Depreciation and amortisation                                                (74.31)        (64.07)
           Other expenses and exceptional items                                        (467.16)       (405.89)
           Profit before tax                                                            222.42        303.51
           Income tax expense                                                           (58.22)        (74.93)
           Profit after tax for the year                                                164.20        228.58
           Fair value adjustments for NCI (Ind-AS 103)                                   (0.46)         (3.48)
           Profit for the year                                                          163.74        225.10
           NCI’s share of profit for the year                                            81.77        112.41










           300
   297   298   299   300   301   302   303   304   305   306   307